Terumo (Terumo) Net Margin %

: 12.47% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Terumo's Net Income for the three months ended in Dec. 2023 was $207 Mil. Terumo's Revenue for the three months ended in Dec. 2023 was $1,660 Mil. Therefore, Terumo's net margin for the quarter that ended in Dec. 2023 was 12.47%.

The historical rank and industry rank for Terumo's Net Margin % or its related term are showing as below:

TRUMY' s Net Margin % Range Over the Past 10 Years
Min: 7.3 Med: 11.74 Max: 15.53
Current: 11.19

TRUMY's Net Margin % is ranked better than
74.45% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs TRUMY: 11.19

Terumo Net Margin % Historical Data

The historical data trend for Terumo's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Margin %

13.26

13.55

12.59

12.63

10.89

Terumo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																13.91	9.47	10.48	12.05	12.47

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Terumo's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Terumo Net Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Net Margin % distribution charts can be found below:

* The bar in red indicates where Terumo's Net Margin % falls into.

Terumo Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Terumo's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	668.279	/	6136.336
	=	10.89 %

Terumo's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	207.006	/	1660.47
	=	12.47 %

Terumo (OTCPK:TRUMY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Terumo Net Margin % Related Terms

Thank you for viewing the detailed overview of Terumo's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo (Terumo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

TRUMF:USA 4543:Japan TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.